Monopoly Power vs. Political Pressure: What ASML's Q2 Order Book Will Reveal on July 15
Published on 07/11/2026 at 16:41 | Redaktion boerse-global.de
ASML's management has already baked a degree of export disruption into its 2026 revenue forecast of €36 to €40 billion. Whether that buffer is sufficient — or whether Washington and Beijing are about to blow a hole in it — will be decided this Wednesday, when the Dutch lithography giant releases its second-quarter numbers. The market's wait-and-see mood is palpable: shares closed Friday at €1,574.20, down 0.51% on the day and 3.30% over the past week.
The stock now sits 9.94% below its 52-week high of €1,748.00, yet the year-to-date gain remains a blistering 59.28%. Over twelve months, the advance reaches 128.94%. That kind of run has left ASML trading at a price-to-earnings multiple of 60.3 — a level that leaves no room for disappointment. Some analysts peg fair value closer to 53.5 times earnings, meaning even a modest miss on the order intake could trigger a meaningful re-rating.
On the bull side, the arguments are as structural as they come. The company's order backlog stood at €38.8 billion at the start of the year, a cushion that extends well into 2027. The upgrade cycle to high-NA EUV technology is just getting started: each machine costs between €380 million and €400 million, with ten deliveries planned for 2026 and twenty for 2027. Customer demand remains robust — TSMC is budgeting $52 to $56 billion in capital expenditure for 2026, while SK Hynix recently placed a record EUV order worth roughly €7.97 billion. ASML's own production targets are climbing in tandem: at least 60 low-NA EUV systems this year and a goal of 80 in 2027, up from 44 in 2025.
Yet the bull case must contend with an increasingly hostile geopolitical landscape. The MATCH Act, introduced in the U.S. House of Representatives on April 2 and advanced by committee on April 22, would expand existing export restrictions beyond ASML's EUV machines to cover the company's DUV immersion systems — a technology that can still be sold and serviced in China. A companion bill is under discussion in the Senate, though nothing has passed into law. In parallel, the Dutch government is tightening its own export licensing for DUV immersion tools. And on July 11, China announced a temporary ban on helium exports, a gas essential to semiconductor manufacturing — with no end date specified.
Should investors sell immediately? Or is it worth buying Asml?
The shifting exposure to China is already visible in the numbers. In the first quarter of 2026, China's share of ASML's net system revenue fell to 19%, down from 36% in the previous quarter. Management forecasts the full-year figure will land around 20%. South Korea, by contrast, has jumped to 45% of system sales, underscoring how the company's geographic mix is pivoting toward the AI-driven demand from memory and foundry customers. CEO Christophe Fouquet has stated that the 2026 revenue range of €36 to €40 billion already accounts for "possible outcomes of ongoing discussions around export controls." CFO Roger Dassen echoed that in the first-quarter earnings call.
The decisive number on Wednesday will be the second-quarter order intake. The market expects a range of €8 to €10 billion, a step down from the record €13.2 billion booked in the fourth quarter of 2025. A result within or above that range would reinforce the thesis that the AI infrastructure buildout is now in execution, not speculation. A miss, particularly one accompanied by cautious commentary on the helium ban or the MATCH Act, could send the stock back toward recent support levels.
Technically, the current neutral reading of the 14-day relative strength index at 51.1 offers no directional clue. The stock stands 6.53% above its 50-day moving average of around €1,477.77 — a level that would likely be tested on any earnings disappointment. The downside to the 200-day average at €1,166.58 is a reminder of how much faith the market has priced into the long-term uptrend: the current premium to that line is a full 34.94%.
Asml at a turning point? This analysis reveals what investors need to know now.
Investors will be watching the earnings release for three specific data points: the final order-intake figure relative to the Q4 2025 record, the delivery timeline for the ten high-NA EUV machines scheduled this year, and any formal guidance on the impact of the helium restrictions and the evolving Dutch and U.S. export regimes.
For now, ASML's €38.8 billion backlog acts as a powerful shield. The question is whether the MATCH Act, the helium ban, and the tightening Dutch export screws are already chipping away at the foundation — or whether the company's pivot away from China is happening fast enough to make those concerns academic. Wednesday's numbers will provide the first real answer.
Ad
Asml Stock: New Analysis - 11 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
